Your browser doesn't support javascript.
loading
Susceptibility of Multidrug-Resistant Escherichia coli, Klebsiella pneumoniae, and Pseudomonas aeruginosa from Germany to Ceftolozane-Tazobactam, Ceftazidime-Avibactam, and Imipenem-Relebactam.
Kresken, Michael; Wohlfarth, Esther; Wichelhaus, Thomas A; Gatermann, Sören G; Pfennigwerth, Niels; Eisfeld, Jessica; Seifert, Harald.
Affiliation
  • Kresken M; Antiinfectives Intelligence GmbH, Cologne, Germany.
  • Wohlfarth E; Rheinische Fachhochschule Köln gGmbH, Cologne, Germany.
  • Wichelhaus TA; Antiinfectives Intelligence GmbH, Cologne, Germany.
  • Gatermann SG; Institute of Medical Microbiology and Infection Control, University Hospital Frankfurt, Frankfurt am Main, Germany.
  • Pfennigwerth N; Department of Medical Microbiology, German National Reference Centre for Multidrug-Resistant Gram-Negative Bacteria, Ruhr-University Bochum, Bochum, Germany.
  • Eisfeld J; Department of Medical Microbiology, German National Reference Centre for Multidrug-Resistant Gram-Negative Bacteria, Ruhr-University Bochum, Bochum, Germany.
  • Seifert H; Department of Medical Microbiology, German National Reference Centre for Multidrug-Resistant Gram-Negative Bacteria, Ruhr-University Bochum, Bochum, Germany.
Microb Drug Resist ; 29(4): 138-144, 2023 Apr.
Article in En | MEDLINE | ID: mdl-36622756
Subject(s)
Key words
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Health context: 3_ND Database: MEDLINE Main subject: Pseudomonas Infections / Anti-Bacterial Agents Type of study: Observational_studies / Prevalence_studies / Risk_factors_studies Limits: Humans Language: En Journal: Microb Drug Resist Year: 2023 Document type: Article
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Health context: 3_ND Database: MEDLINE Main subject: Pseudomonas Infections / Anti-Bacterial Agents Type of study: Observational_studies / Prevalence_studies / Risk_factors_studies Limits: Humans Language: En Journal: Microb Drug Resist Year: 2023 Document type: Article